Semaglutide News and Research

RSS
Oral semaglutide shows significant promise in improving diabetes control and cardiovascular health, study reveals

Oral semaglutide shows significant promise in improving diabetes control and cardiovascular health, study reveals

GLP-1 receptor agonists effective for weight loss in obesity without diabetes

GLP-1 receptor agonists effective for weight loss in obesity without diabetes

Semaglutide shows significant kidney benefits in non-diabetic obese patients with heart disease

Semaglutide shows significant kidney benefits in non-diabetic obese patients with heart disease

Oral semaglutide shows promising results for type 2 diabetes in routine clinical settings

Oral semaglutide shows promising results for type 2 diabetes in routine clinical settings

Taking semaglutide once weekly may lower the chances of kidney disease, says study

Taking semaglutide once weekly may lower the chances of kidney disease, says study

Increased risk of erectile dysfunction with semaglutide in non-diabetic obese patients

Increased risk of erectile dysfunction with semaglutide in non-diabetic obese patients

SELECT trial shows semaglutide reduces kidney decline in obese patients

SELECT trial shows semaglutide reduces kidney decline in obese patients

Sharp uptick in youth using wegovy and ozempic, study reports

Sharp uptick in youth using wegovy and ozempic, study reports

From research to practice: Closing the divide in obesity management

From research to practice: Closing the divide in obesity management

Anti-obesity medications slash heart disease risk in obese patients, study finds

Anti-obesity medications slash heart disease risk in obese patients, study finds

New study reveals brain clearance of toxins is reduced during sleep and anesthesia

New study reveals brain clearance of toxins is reduced during sleep and anesthesia

Semaglutide shows significant weight loss and health benefits in four-year obesity study

Semaglutide shows significant weight loss and health benefits in four-year obesity study

Sustainable weight loss with personalized semaglutide dosing

Sustainable weight loss with personalized semaglutide dosing

Social media channels could be harnessed to provide information about obesity to young people

Social media channels could be harnessed to provide information about obesity to young people

Semaglutide improves heart failure symptoms and reduces loop diuretic dose

Semaglutide improves heart failure symptoms and reduces loop diuretic dose

Enhanced weight loss outcomes with GLP-1 analogues and bupropion/naltrexone combination

Enhanced weight loss outcomes with GLP-1 analogues and bupropion/naltrexone combination

Popular diabetes drugs not linked to thyroid cancer risk, study finds

Popular diabetes drugs not linked to thyroid cancer risk, study finds

AI-based analysis uncovers two plant extracts with potential as GLP-1 agonist weight loss pills

AI-based analysis uncovers two plant extracts with potential as GLP-1 agonist weight loss pills

Unlocking weight loss through exercise mimicry with metformin

Unlocking weight loss through exercise mimicry with metformin

New research sheds light on how GLP-1 obesity drugs may change food cravings

New research sheds light on how GLP-1 obesity drugs may change food cravings

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.